In 2019, stem cells will give new hope to a growing number of diseases.

A growing number of scientists believe that stem cells, which play a role in the treatment of many diseases, are essential for repairing and building human tissue.

"Stem cells are increasingly being used for diseases that are not traditionally treatable, including bone tissue damage, heart disease, degenerative diseases and organ failure," said university of Sydney scientists, who published their findings in the proceedings of the national academy of sciences.

Su guohui, a neuroanatomist and academician of the Chinese Academy of Sciences, also said at the conference that in the treatment of diseases, some traditional methods may not be able to overcome the defense line of diseases, but in the future stem cells may provide a new direction of treatment to fight diseases.

At the beginning of 2019, there are already some exciting new stem cell achievements, which either solve some of the difficulties in the development of stem cell therapies, or solve the key problems in the treatment of diseases with stem cells, and bring new hope to life and health!

New stem cell results offer new hope for more disease treatments

Scientists have been trying to find new ways to treat diseases or find new ways to make stem cell therapies more effective. New research is driving the development of stem cell treatments for diseases.

Scientists at the university of Sydney in the proceedings of the national academy of sciences, according to new results published they find a cheap and fast way to create stem cells, they found a original elastic protein can be used to achieve this goal, this protein to make the organization has the ability to extend and retract, can promote the expansion of stem cells, and keep the ability of stem cells to develop into different cell. The researchers believe the results could help address the global shortage of stem cells and could reduce the cost of many cell therapies, which could benefit more patients in the future.

Scientists at the university of California, San Francisco, have discovered a new way to treat type 1 diabetes by using stem cells to grow mature insulin-producing cells.

For a long time, scientists could only make immature cells that did not respond to blood sugar levels or produce insulin normally. But us scientists have found that mimicking the formation of islet cells in the pancreas helps these cells mature. In this study, they used stem cells to create insulin-producing cells that look and act very similar to human islet beta cells, and that show full function in animals, producing insulin and responding to changes in blood sugar.

2019 is the year of the journey, and it is believed that more new research results will be exported and more stem cell treatment problems will be gradually solved.

Stem cells are being used to treat more and more diseases

In recent years, stem cells have been used to treat more and more diseases, including bone damage, cardiovascular disease, degenerative diseases, organ failure and so on.

Take progeria. Progeria is a rare disease in which the body ages 5 to 10 times faster than normal, leading to organ failure. Currently, there is no effective treatment. But advances in stem cell technology in recent years have given new hope to progeria, a disease that traditional medicine has failed to treat effectively. (video, | placental stem cell therapy for progeria)

Progeria is one of many rare diseases. Rare diseases have become one of the biggest challenges faced by human medicine. However, the development of stem cell technology has changed the treatment pattern of an increasing number of rare diseases, such as polysaccharides storage disease and crohn's disease. At the same time, some stem cell therapies for rare diseases have entered the late clinical stage, such as als (stem cell therapy NurOwn®), Parkinson's (stem cell therapy isc-hpnsc) and other rare diseases are getting closer to clinical application.

China attaches great importance to the development of stem cell therapy technology. From 2016 to 2018, clinical research on stem cells supported by central government funds involved macular degeneration, spinal cord injury, graft-versus-host disease, heart failure, myocardial infarction, liver disease, severe acute kidney injury and other diseases.

Up to now, there are more than 30 archival projects of stem cell clinical research in China, covering nearly 30 diseases, including type 2 diabetes, systemic lupus erythematosus, cerebral palsy, osteoarthritis, uterine adhesion, macular degeneration, myocardial infarction, psoriasis, Parkinson's disease, colitis, liver cirrhosis, etc.

In 2019, the central government will continue to allocate funds to support stem cell transplantation to treat major diseases. In 2019, the number of stem cell clinical research registerings will continue to increase, as will the number of indications involved. In 2019, stem cells will give new hope to more and more diseases.